New Guidelines to Treat Depression in Pregnant Women

Regular inquiry about well-being vs. universal screening is recommended to detect depression during pregnancy and after birth.

A screening tool is used to detect depression in pregnant and postpartum women. However, a new guideline recommends clinicians to ask patients about their well-being as part of usual care.//

The new guideline was from the Canadian Task Force on Preventive Health Care and was published in CMAJ (Canadian Medical Association Journal).

Depression During Pregnancy may Increase Offspring�s Risk of Mental Health Issues
Children born to mothers who struggled with depression during pregnancy also have a slightly increased risk of depression.

‘Regular inquiry about well-being vs. universal screening is recommended to detect depression during pregnancy and after birth.’

"Depression in pregnant and postpartum people is devastating, with a massive burden for families, and it’s critical to detect it," says Dr. Eddy Lang, an Emergency Physician and Professor at the Cumming School of Medicine, University of Calgary and Chair of the task force’s pregnancy and postpartum working group.

However, there is little evidence that universal screening for depression using a standard questionnaire and cut-off score improves longer-term outcomes for these patients, indicating more research is needed.

"We were disappointed to find insufficient evidence of benefit to universal screening with a questionnaire and cut-off score; rather, it’s best for primary care clinicians to focus on asking patients about their well-being at visits," says Dr. Lang. "The emphasis is on an individualized rather than one-size-fits-all approach."

One Out of 10 Women Experience Depression During Pregnancy
Researchers from University of Carolina found that women who have suffered eating disorders carry a greater risk of depression during pregnancy.

In creating the guideline, the task force engaged patients to understand their values and preferences around screening to inform recommendations. Participants felt strongly that a discussion about depression with their health care provider during pregnancy and the postpartum period is critical.

The guideline is aimed at healthcare providers in Canada, including physicians, nurses, midwives and other healthcare professionals who interface with pregnant and postpartum patients. It replaces the previous guideline from the task force, published in 2013.

Severity Of Mother�s Depression During Pregnancy Causes Autism And ADHD
Exposure to antidepressant drugs during pregnancy does not increase the risk for autism and ADHD. It’s the severity of mother’s depression that increases the risk.

The guideline applies to pregnant and postpartum people in the first year after delivery. It does not apply to pregnant or postpartum people with a history of depression or who are being assessed or treated for other mental disorders.

What does this mean for clinicians?

Clinicians should:

ask patients about their well-being as part of usual care,
consider not using a standardized tool with a cut-off score to screen every patient,
remain vigilant for depression, and
use clinical judgment to decide on further steps.

"Given the health implications of depression during pregnancy and the postpartum period, it’s essential to check in with people about how they’re feeling," says task force member Dr. Emily McDonald, Associate Professor, at McGill University and a Physician at McGill University Health Centre.

Children of Depressed Mothers Face a Higher Risk of Asthma
Pregnant mothers who suffered from clinically significant distress such as anxiety or depression are more likely to have children with asthma, reports a new study.

"If clinicians are uncertain about how to start the conversation, they could refer to questionnaires for discussion prompts, which is different than formal screening that would use a cut-off score to determine next steps."

As the practice of screening varies in Canada, with several provinces and territories recommending screening using a standardized tool, updated guidance was needed.

"Jurisdictions that employ formal screening may wish to reconsider this practice given the very uncertain evidence of benefit," says task force member Dr. Brenda Wilson, a public Health Physician and professor at Memorial University, St. John’s, Newfoundland, and task force Co-chair.

"What’s essential is clinical vigilance for depression as part of usual care, as engaging in practices with no proven benefit can take away from other health issues."

Source-Eurekalert